Gritstone Oncology, Inc. (GRTS): Price and Financial Metrics
Gritstone Oncology, Inc. (GRTS)
Today's Latest Price: $18.42 USD
Updated Jan 28 11:16am
Add GRTS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
GRTS Stock Summary
- GRTS's went public 2.34 years ago, making it older than just 5.3% of listed US stocks we're tracking.
- GRTS's price/sales ratio is 182.85; that's higher than the P/S ratio of 97.5% of US stocks.
- The volatility of Gritstone Oncology Inc's share price is greater than that of 97.74% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Gritstone Oncology Inc, a group of peers worth examining would be VBLT, SYBX, ORMP, ARCT, and EVGN.
- Visit GRTS's SEC page to see the company's official filings. To visit the company's web site, go to gritstoneoncology.com.
GRTS Stock Price Chart Interactive Chart >
GRTS Price/Volume Stats
| Current price | $18.42 | 52-week high | $35.20 |
| Prev. close | $17.30 | 52-week low | $2.54 |
| Day low | $17.53 | Volume | 795,660 |
| Day high | $20.08 | Avg. volume | 8,841,245 |
| 50-day MA | $6.76 | Dividend yield | N/A |
| 200-day MA | $5.16 | Market Cap | 695.61M |
Gritstone Oncology, Inc. (GRTS) Company Bio
Gritstone Oncology, Inc., an immuno-oncology company, engages in developing personalized cancer immunotherapies for various cancer types in the United States. It is developing GRANITE-001, a personalized immunotherapy product for cancer patients; and SLATE-001 for patients with common tumor neoantigens. The company was founded in 2015 and is based in Emeryville, California.
Loading social stream, please wait...